Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion type Assertion NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_head.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion description "[Accordingly, CRIPTO has been detected at very low levels in the plasma of healthy volunteers, whereas its levels are significantly higher in patients with breast, colon or glioblastoma tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_provenance.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion evidence source_evidence_literature NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_provenance.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion SIO_000772 25629528 NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_provenance.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion wasDerivedFrom befree-2016 NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_provenance.
- NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_assertion wasGeneratedBy ECO_0000203 NP1259087.RAgCpUDdalgXdFcRZe2k_qaRNL53-Z9qwIfPA4uGjRuKI130_provenance.